30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Pharmaceuticals & Medical Research Sector Insider Trading Activity

Suivez les achats et ventes d’initiés sur les actions de Healthcare. Découvrez quels dirigeants achètent, l’activité nette des initiés et le pourcentage du flottant échangé parmi 2,040 sociétés.
Les informations fournies dans ce classement sont à titre informatif uniquement et ne constituent pas un conseil financier. Nous ne recommandons aucun investissement spécifique basé sur ces critères.
Entreprises
Données
Abonnez-vous pour accéder à l'ensemble des données
Entreprise Branche d'activité Cap. boursière (USDm) # acheteurs nets Valeur nette ($) % du flottant acheté % d'actions détenues par les initiés
Pharmaceuticals Mega (1.0tn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals Mega (589.5bn) -1–5 -$1M–$10M -0–15% 0–15%
US Abbvie Inc (ABBV)
Pharmaceuticals Mega (429.6bn) 0 Aucune activité — 0–15%
Pharmaceuticals Mega (326.2bn) 0 Aucune activité — —
Pharmaceuticals Mega (309.8bn) 0 Aucune activité — 0–15%
Pharmaceuticals Mega (290.1bn) -1–5 -$1M–$10M -0–15% 0–15%
CH Novartis AG (NOVN)
Pharmaceuticals Mega (287.4bn) -1–5 -$1M–$10M -0–15% 0–15%
US Amgen Inc (AMGN)
Pharmaceuticals Large (179.0bn) -1–5 -$100K–$1M -0–15% 0–15%
DK Novo Nordisk A/S (NOVO-B)
Pharmaceuticals Large (164.0bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Large (155.9bn) 0 Aucune activité — 0–15%
US Pfizer Inc (PFE)
Pharmaceuticals Large (146.5bn) -1–5 -< $100K -0–15% 0–15%
Pharmaceuticals Large (115.6bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Large (112.9bn) 0 Aucune activité — 0–15%
FR Sanofi SA (SAN)
Pharmaceuticals Large (107.6bn) 0 Aucune activité — 0–15%
GB GSK plc (GSK)
Pharmaceuticals Large (101.7bn) 11–20 $100K–$1M 0–15% 0–15%
AU CSL Ltd (CSL)
Pharmaceuticals Large (90.6bn) 0 Aucune activité — 0–15%
US Celgene Corp (CELG)
Pharmaceuticals Large (77.0bn) 0 Aucune activité — —
Biotechnology & Medical Research Large (73.5bn) 0 Aucune activité — 0–15%
US Allergan plc (AGN)
Pharmaceuticals Large (63.7bn) 0 Aucune activité — 0–15%
BE Ucb SA (UCB)
Pharmaceuticals Large (59.7bn) 0 Aucune activité — 15–50%
NL argenx SE (ARGX)
Biotechnology & Medical Research Large (57.8bn) -1–5 -$1M–$10M -0–15% —
Biotechnology & Medical Research Large (47.7bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Large (43.3bn) 1–5 $100K–$1M 0–15% 0–15%
US Seagen Inc (SGEN)
Biotechnology & Medical Research Large (43.2bn) 0 Aucune activité — 0–15%
DE Bayer AG (BAYN)
Pharmaceuticals Large (41.8bn) 1–5 $1M–$10M 0–15% —
Biotechnology & Medical Research Large (40.1bn) 0 Aucune activité — 0–15%
GB Haleon PLC (HLN)
Pharmaceuticals Large (40.1bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals Large (38.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Biotechnology & Medical Research Large (37.7bn) -1–5 -$100K–$1M -0–15% 0–15%
Biotechnology & Medical Research Large (36.1bn) 0 Aucune activité — 0–15%
US Zoetis Inc (ZTS)
Pharmaceuticals Large (34.1bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals Large (32.0bn) 0 Aucune activité — 50%+
Pharmaceuticals Large (30.5bn) 0 Aucune activité — 0–15%
US Biogen Inc (BIIB)
Pharmaceuticals Large (29.8bn) 0 Aucune activité — 0–15%
Pharmaceuticals Large (26.6bn) 0 Aucune activité — 0–15%
US Moderna Inc (MRNA)
Biotechnology & Medical Research Large (24.5bn) -1–5 -$100K–$1M -0–15% 0–15%
Biotechnology & Medical Research Large (23.9bn) -1–5 -$10M–$100M -0–15% 15–50%
DE Biontech SE (BNTX)
Biotechnology & Medical Research Large (23.3bn) -1–5 -$1M–$10M -0–15% 50%+
Biotechnology & Medical Research Large (23.2bn) -1–5 -$100K–$1M -0–15% 0–15%
US Incyte Corp (INCY)
Biotechnology & Medical Research Large (21.5bn) -1–5 -$1M–$10M -0–15% 0–15%
US Insmed Inc (INSM)
Biotechnology & Medical Research Large (21.4bn) -1–5 -$1M–$10M -0–15% 0–15%
Biotechnology & Medical Research Large (20.3bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Large (20.0bn) 0 Aucune activité — 0–15%
Pharmaceuticals Large (18.9bn) -1–5 -$1M–$10M -0–15% 50%+
US Viatris Inc (VTRS)
Pharmaceuticals Large (18.3bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Large (18.2bn) -11–20 -$10M–$100M -0–15% 0–15%
Pharmaceuticals Large (16.6bn) -6–10 -$1M–$10M -0–15% 0–15%
DK Genmab A/S (GMAB)
Biotechnology & Medical Research Large (16.5bn) 0 Aucune activité — —
Biotechnology & Medical Research Large (16.5bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Large (16.0bn) 1–5 -$1M–$10M -0–15% 0–15%
IN Cipla Ltd (CIPLA)
Pharmaceuticals Large (15.9bn) 0 Aucune activité — 15–50%
Pharmaceuticals Large (15.7bn) 0 Aucune activité — 50%+
Pharmaceuticals Large (15.1bn) -1–5 -$1M–$10M -0–15% 0–15%
FR Ipsen SA (IPN)
Pharmaceuticals Large (15.0bn) 0 Aucune activité — 50%+
Biotechnology & Medical Research Large (14.0bn) 0 Aucune activité — 0–15%
Pharmaceuticals Large (13.5bn) 0 Aucune activité — 50%+
US Exelixis Inc (EXEL)
Biotechnology & Medical Research Large (13.4bn) -6–10 -$1M–$10M -0–15% 0–15%
Pharmaceuticals Large (13.1bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Large (12.9bn) 0 Aucune activité — 15–50%
Pharmaceuticals Large (12.9bn) 0 Aucune activité — 50%+
Pharmaceuticals Large (12.7bn) 0 Aucune activité — 15–50%
Biotechnology & Medical Research Large (12.6bn) -1–5 -$1M–$10M -0–15% 15–50%
Biotechnology & Medical Research Large (12.6bn) 0 Aucune activité — 0–15%
Pharmaceuticals Large (12.3bn) 1–5 $100K–$1M 0–15% 0–15%
Biotechnology & Medical Research Large (12.1bn) -1–5 -$100K–$1M -0–15% 0–15%
US MyoKardia Inc (MYOK)
Biotechnology & Medical Research Large (12.0bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Large (11.5bn) -1–5 -$100K–$1M -0–15% 0–15%
US Catalent Inc (CTLT)
Pharmaceuticals Large (11.5bn) 0 Aucune activité — 0–15%
Pharmaceuticals Large (11.5bn) 0 Aucune activité — 50%+
FI Orion Oyj (ORNBV)
Pharmaceuticals Large (11.2bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Large (10.9bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Large (10.9bn) -1–5 -$10M–$100M -0–15% 0–15%
Biotechnology & Medical Research Large (10.9bn) 1–5 $100M+ 0–15% 50%+
Biotechnology & Medical Research Large (10.9bn) -6–10 -$10M–$100M -0–15% 0–15%
Biotechnology & Medical Research Large (10.8bn) 0 Aucune activité — 0–15%
Pharmaceuticals Large (10.6bn) -1–5 -$100K–$1M -0–15% 0–15%
FR Abivax SA (ABVX)
Biotechnology & Medical Research Mid (9.8bn) 0 Aucune activité — 0–15%
US Nuvalent Inc (NUVL)
Biotechnology & Medical Research Mid (9.8bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Mid (9.6bn) 0 Aucune activité — 15–50%
Biotechnology & Medical Research Mid (9.3bn) -6–10 -$1M–$10M -0–15% 15–50%
Biotechnology & Medical Research Mid (9.1bn) 0 Aucune activité — 0–15%
Pharmaceuticals Mid (8.9bn) -1–5 -$1M–$10M -0–15% 0–15%
IE ICON PLC (ICLR)
Biotechnology & Medical Research Mid (8.9bn) 0 Aucune activité — 0–15%
IE Alkermes Plc (ALKS)
Biotechnology & Medical Research Mid (8.8bn) -1–5 -$100K–$1M -0–15% 0–15%
US ImmunoGen Inc (IMGN)
Biotechnology & Medical Research Mid (8.7bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Mid (8.6bn) 0 Aucune activité — 0–15%
US Mylan NV (MYL)
Pharmaceuticals Mid (8.6bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Mid (8.4bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Mid (8.2bn) -1–5 -$100M+ -0–15% 0–15%
Biotechnology & Medical Research Mid (8.2bn) 0 Aucune activité — 50%+
Biotechnology & Medical Research Mid (8.1bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Mid (8.1bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Mid (8.0bn) -1–5 -$100K–$1M -0–15% 0–15%
Biotechnology & Medical Research Mid (7.9bn) -1–5 -$100K–$1M -0–15% 0–15%
Biotechnology & Medical Research Mid (7.9bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Mid (7.9bn) -1–5 -$10M–$100M -0–15% 0–15%
Biotechnology & Medical Research Mid (7.8bn) -6–10 -$10M–$100M -0–15% 50%+
Biotechnology & Medical Research Mid (7.7bn) 0 Aucune activité — 15–50%
Biotechnology & Medical Research Mid (7.7bn) -1–5 -$1M–$10M -0–15% 0–15%
ES Grifols SA (GRF)
Pharmaceuticals Mid (7.6bn) 0 Aucune activité — 15–50%